The tear substitutive therapy for prophylaxis and treatment of dry eye after cataract surgery

Purpose: To study the efficiency of tear substitutes based on hyaluronic acid at the patients after phacoemulsification for prophylaxis and postoperative therapy of dry eye syndrome.

Methods: 168 patients (168 eyes) were examined before cataract surgery. The average age was 69.2±5.7 years old. Patients were divided into four groups according to the presence of eye dry syndrome and following tear substitutive therapy. 55 patients with a mild case of DES (the first group) were treated with Vismed® eye drops 1 drop given 3 times a day for 1 week before surgery and postoperatively. 10 patients with a moderate case of DES (second group) were treated with Vismed gel® to use with the same periodicity. Patients without DES were divided into two groups: 50 of them (third group) were treated to use Vismed® 1 drop 3 times a day postoperatively, the rest 53 didn’t undergo the course of treatment — «checkout group». The observation period was 45 days after operation. The study of tear secretion and osmolarity of tear fluid was performed before and after operative period.

Results: 65 patients were first diagnosed a mild or moderate case of DES. On the third day after operation every group showed the increase of tear osmolarity, it was especially noticable among the patients of «checkout group» from 294 to 314 mOsm / l at the average. On the seventh day after operation all groups showed further negative dynamics, and in the «checkout» group comparing to initial indices was registered noticable worsening of the studied parameters (р≤0.05). By the 14th day after phacoemulsification patients from the 1st and the 3rd groups displayed the tendency to restoration of indices to the preoperative values. Indices of osmolarity and tear secretion restored among the patients from the 1st and the 2nd groups by the 21st day and even improved in comparison to the preoperative values of group 3. Meanwhile, «checkout» group’s indices fell to a level even lower than before the operation. By the end of the experiment (45th day after operation) decrease of osmolarity and increase of functional tests was registered among all the groups, however, the results were more evident among the groups who underwent tear substitutive treatment.

Conclusion: Performed experiment confirmed that tear substitutive therapy conducted in the postoperatively speeds up recovery and restores indices of tear secretion and osmolarity.

1. Бржеский В. В., Сомов Е. Е. Роговично-конъюнктивальный ксероз (диагностика, клиника, лечение). Изд. 2‑е, част. перераб. и доп., СПб.: «Левша. Санкт-Петербург», 2003.

2. Полунин Г. С., Куренков В. В., Сафонова Т. Н., Полунина Е. Г. Новая клиническая классификация синдрома «сухого глаза» // Рефракц. хирургия и офтальмология. — 2003. –Т. 3, № 3. — С. 53‑56.

3. Майчук Д. Ю. Клинические формы вторичного «сухого глаза»: патогенез, терапия и профилактика. Мат.научно- практ.конф.: Новые технологии в лечении заболеваний роговицы. М., 2004. — С. 702‑706.

4. Baudoum C. A new approach for better comprehension of diseases of ocular surface // J. Fr. Ophtalmol. — 2007. — Vol. 30, № 3. — P. 239‑249

5. Бойко А. А., Дубинкина В. О., Ерёменко А. И., Куликова О. В., Янченко С. В. Профилактика комбинированного синдрома сухого глаза у пациентов старшей возрастной группы после катарактальной хирургии // Клин. офтальмол. —2006. –Т. 7, № 3. — С. 122‑125.

6. Смиренная Е. В. Синдром «сухого глаза» и принципы его медикаментозной коррекции после интрастромальных эксимерлазерных операций. Мат.научно- практ.конф.: Современные принципы диагностики и лечения заболеваний роговицы и склеры. М., 2007, Т.2. — С. 372‑374.

7. Hardten DR. Dry eye disease in patients after cataract surgery // Cornea. —2008. — Vol. 27, № 7. P. 855

8. Li X, Hu L, Hu J, Wang W. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery // Cornea. — 2009. — Vol. 26, № 1. P. 16‑S20.

9. Yang Kyeung Cho, MD, PhD and Man Soo Kim, MD, PhD. Dry Eye After Cataract Surgery and Associated Intraoperative Risk Factors // Korean J Ophthalmol. —2009. — Vol. 23, № 2. — P. 65‑73.

10. Кашникова О. А., Майчук Д. Ю., Куренков В. В., Полунин Г. С. Профилактика и терапия симптоматического сухого глаза в фоторефракционной хирургии // Рефракц. хирургия и офтальмология. — 2001. — Т.1, № 3. — С. 22‑26.

11. Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma // Acta ophthalmol. — 2008. — Vol.86. — P. 716‑726.

12. Яни Е. Ф., Майчук Ю. Ф. Новые препараты группы слезозаместителей. Труды конференции: Роль и место фармакотерапии в современной офтальмологической практике. СПб, 2006. — С. 127‑128.

13. Fukuda M., Miyamoto Y., Miyara Y. et al. Hyaluronic acid in tear fl uid and its synthesis by corneal epithelial cells // Asia-Pacifi c J. Ophthalmol. — 1998. —№ 10. — P. 20‑22.

14. Nakamura M., Hikida M., Nakano T. et al. Characterization of water retentive properties of hyaluronan // Cornea. — 1993. — № 5. — P. 433‑436.

15. Saettone M. F., Chetoni P., Torracca M. T. et al. Evaluation of mucoadhesive properties and vivo activity of ophthalmic vehicles based on hyaluronic acid //Int. J. Pharmacol. — 1989. — Vol. 51. — P. 203‑212.

16. WISMED. Брошюра производителя препаратов TRB Chemedica, ООО «Робертс Хелскеар». 2006.

17. Майчук Ю. Ф., Яни Е. В. Клиническая оценка препаратов на основе гиалуроновой кислоты. Визмед глазные капли и Визмед гель в монодозах в лечении синдрома сухого глаза // Рефракц. хирургия и офтальмология. — 2008. — Т8,

18. № 4. — С. 35‑42.

19. Смиренная Е. В. Изучение клинической эффективности препарата Визмед лайт при профилактике и лечении симптоматического «сухого глаза» после интрастромальной эксимерлазерной коррекции // Рефракц. хирургия и оф-

20. тальмология. — 2010. — Т. 10, № 2. — С. 40‑45.

21. Brignole F., Pisella P-J., Dupas B. et al. Effi cacy and satefy of 0,18 % sodium hyaluronate in patients with moderate dry eye syndrome and superfi cial keratitis // Graefe’s Arch. Clin. Ophthalmol. — 2005. Vol. 243. — P. 531‑538.

22. Baeyens V., Baudouin C. Effi cacy and satefy of VISMED in patients with bilateral moderate dry eye syndrome: A double-blind, randomized, saline-controlled, multicentre parallel group phase III study. 2005. Hospital Ambroise-Pare. Boulonge

23. / France-TRB Chemedica int. / Geneva / Switzerland — presented at the ARVO. F. L. USA. 4: P. 25‑29.